Seekingalpha

Published September 14, 2026 · Updated September 15, 2026

Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety

Read the full story at Seekingalpha

Definium Therapeutics shares rise after phase 3 DT120 ( LSD ) results hit endpoints in anxiety. Pre-NDA Q4, filing H1 2027. Read more here.